Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01350583 · ClinicalTrials.gov registry record · NA
Bicarbonate for Tumor Related Pain
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT01350583: Clinical Trial NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT01350583 is a NA study that was terminated before completion, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01350583, a NA study, was terminated before completion, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to: * Determine how well people tolerated sodium bicarbonate taken by mouth in higher doses than those usually given for heartburn. * Determine if sodium bicarbonate can reduce cancer-related pain. Right now, the investigators do not know for sure if these higher doses will be well tolerated or if they will reduce the pain associated with cancer. The investigators are doing this study to see if sodium bicarbonate is well tolerated and if it can reduce the requirements for pain medications.
Primary Outcome
Percent of patients with greater than 30% improvement in pain intensity by visual assessment scale.
Interventions
- DRUG Sodium Bicarbonate (NaHCO3)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2010-08 |
| Est. Completion | 2012-05 |
| Phase | NA |
Why NCT01350583 stopped before completion
NCT01350583 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Sodium Bicarbonate (NaHCO3) is the first listed.
NCT01350583 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01350583 about?
NCT01350583 is a clinical study titled "Bicarbonate for Tumor Related Pain". The purpose of this study is to: * Determine how well people tolerated sodium bicarbonate taken by mouth in higher doses than those usually given for heartburn. * Determine if sodium bicarbonate can reduce cancer-related pain. Right now, the investigators do not know for sure if these higher doses ...
What is the current status of trial NCT01350583?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2010-08. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01350583?
The interventions under investigation include: Sodium Bicarbonate (NaHCO3) (DRUG).
Who is sponsoring clinical trial NCT01350583?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01350583's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia